Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.

Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK ...

Markets worldwide defied expectations in 2024 led by the dominating performance of mega-cap technology stocks known as the ...

Former Washington state Sen. Reuven Carlyle breaks down which bills are safe and which are on the chopping block,.

Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

For the very first time, the storied Bemelmans Bar within The Carlyle, A Rosewood Hotel, has popped up outside of its Upper ...

A proposal backed by Gov. Bob Ferguson to increase student access to free meals served at public schools also appears dead, at least for now.

They invest in public stocks and bonds, and their clients are increasingly sensitive to costs. Their most popular products these days are passive index trackers with razor-thin fees, often just a few ...

Bluebird bio will be acquired by investment firms Carlyle and SK Capital Partners, marking the end to its turbulent time as a ...

The Pacers center had a big night against the Grizzlies and Carlisle had a message for the rest of the league.

English was removed as an official language after a long struggle… It is not just Urdu that I demanded (among languages for ...